by PEAK Medicals | 6 November 2024
Antibody Drug Conjugates WELCOME & INTRODUCTION BY HOST Alessandra Curioni EMERGING TRENDS & CLINICAL IMPACT OF ADCs IN GENITOURINARY CANCERS Giuseppe Banna CURRENT AND FUTURE STANDARDS OF ADCs IN BREAST CANCER CARE Paolo Tarantino NEW DEVELOPMENTS IN LUNG CANCER CARE...
by PEAK Medicals | 12 June 2024
Lung Cancer (ASCO 2024) Welcome & introduction by host Alfredo Addeo WHAT’S NEW IN TARGETED THERAPIES FOR NSCLC? XIUNING LE LATEST INSIGHTS IN ADCS FOR LUNG CANCER LIZZA HENDRIKS NEW ADVANCES IN IMMUNOTHERAPIES FOR LUNG CANCER ALFREDO ADDEO  } 1 h 32 min Get Your CME...
by PEAK Medicals | 30 April 2024
HER2 in Lung, GYNE & GI Cancers Welcome & introduction by host Ilaria Colombo Clinical implications of HER2 in gastrointestinal cancers Florian Lordick Treatment considerations for HER2-positive lung cancer Maximilian Hochmair Latest treatment updates in...
by PEAK Medicals | 6 February 2024
Biomarkers in GI & Lung The Significance of Biomarkers in GI Oncology for My Therapy Decision Sara De Dosso Biomarkers in GI Oncology: The Tests We Perform in Gastric and GEJ Today Rupert Langer Current Standards in in Lung Cancer Therapy: Which Biomarkers We...
by PEAK Medicals | 24 January 2024
Early NSCLC Welcome & introduction by host Isabelle Opitz Doing more with less: state of the art in tissue acquisition Carolin Steinack Current standards for pathology reporting in lung cancer Lukas Bubendorf Recent advances in thoracic surgery in lung cancer...
